The p38 MAP kinase pathway modulates the hypoxia response and glutamate receptor trafficking in aging neurons.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26731517.
- Also identified by DOI 10.7554/eLife.12010 and PMC identifier 4775213.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Neurons are sensitive to low oxygen (hypoxia) and employ a conserved pathway to combat its effects. Here, we show that p38 MAP Kinase (MAPK) modulates this hypoxia response pathway in C. elegans. Mutants lacking p38 MAPK components pmk-1 or sek-1 resemble mutants lacking the hypoxia response component and prolyl hydroxylase egl-9, with impaired subcellular localization of Mint orthologue LIN-10, internalization of glutamate receptor GLR-1, and depression of GLR-1-mediated behaviors. Loss of p38 MAPK impairs EGL-9 protein localization in neurons and activates the hypoxia-inducible transcription factor HIF-1, suggesting that p38 MAPK inhibits the hypoxia response pathway through EGL-9. As animals age, p38 MAPK levels decrease, resulting in GLR-1 internalization; this age-dependent downregulation can be prevented through either p38 MAPK overexpression or removal of CDK-5, an antagonizing kinase. Our findings demonstrate that p38 MAPK inhibits the hypoxia response pathway and determines how aging neurons respond to hypoxia through a novel mechanism.
Medical subject headings
- Caenorhabditis elegans
- Caenorhabditis elegans Proteins
- Cell Hypoxia
- MAP Kinase Signaling System
- Neurons
- Receptors, Glutamate
- p38 Mitogen-Activated Protein Kinases